.
ISSN 2063-5346
-
BIOCHEMISTRY OF FASTING – A REVIEW ON METABOLIC SWITCH AND AUTOPHAGY.
Volume - 13 | Issue-1
-
ONE-POT ENVIRONMENT FRIENDLY SYNTHESIS OF IMINE DERIVATIVE OF FURFURAL AND ASSESSMENT OF ITS ANTIOXIDANT AND ANTIBACTERIAL POTENTIAL
Volume - 13 | Issue-1
-
MODELING AND ANALYSIS OF MEDIA INFLUENCE OF INFORMATION DIFFUSION ON THE SPREAD OF CORONA VIRUS PANDEMIC DISEASE (COVID-19)
Volume - 13 | Issue-1
-
INCIDENCE OF HISTOPATHOLOGICAL FINDINGS IN APPENDECTOMY SPECIMENS IN A TERTIARY CARE HOSPITAL IN TWO-YEAR TIME
Volume - 13 | Issue-1
-
SEVERITY OF URINARY TRACT INFECTION SYMPTOMS AND THE ANTIBIOTIC RESISTANCE IN A TERTIARY CARE CENTRE IN PAKISTAN
Volume - 13 | Issue-1
PRO-BNP LEVELS FOR PATIENTS WITH 2nd TYPE OF DM: A PROSPECTIVE, OBSERVATIONAL, NON-INTERVENTIONAL COHORT STUDY
Main Article Content
Abstract
The heart's left ventricle produces pre-proBNP and -mL, respectively. BNPmL, respectively. “Type 2 DM patients are likely to develop heart failure. Pro-BNP levels should be examined in acute heart failure patients”. Non-acute BNP and proBNP levels are 35 and 125 pg/mL. The acute cutoffs are 100 pg/mL BNP and 300 proBNP. Studies have found that asymptomatic Type 2 DM patients had their pro-BNP levels evaluated. Hence, in our study, we found that pro-BNP is linked favorably with diastolic dysfunction symptoms and negatively with LVEF. “ProBNP levels in type 2 DM patients may indicate heart failure and its prognosis”.
Article Details
